Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-26-017941
Filing Date
2026-03-16
Accepted
2026-03-16 09:18:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 eliciotherapeuticsinc-424b5.htm 424B5 421518
2 eliciologoa.jpg GRAPHIC 12164
3 image_0a.jpg GRAPHIC 26290
  Complete submission text file 0001628280-26-017941.txt   475812
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-293861 | Film No.: 26754751
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)